Anidulafungin and fluconazole for candidiasis - Reply

被引：0
|
作者：
Reboli, Annette C. [1 ]
Wible, Michele
Walsh, Thomas J.
机构：
[1] Cooper Univ Hosp, Camden, NJ 08103 USA
[2] Wyeth Ayerst Res, Collegeville, PA 19426 USA
[3] NCI, Bethesda, MD 20892 USA
来源：
NEW ENGLAND JOURNAL OF MEDICINE | 2007年 / 357卷 / 13期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1348 / 1348
页数：1
相关论文
共 50 条
  • [1] Anidulafungin and fluconazole for candidiasis
    Aberegg, Scott K.
    O'Brien, James M., Jr.
    NEW ENGLAND JOURNAL OF MEDICINE, 2007, 357 (13): : 1347 - 1347
  • [2] Anidulafungin versus fluconazole for invasive candidiasis
    Reboli, Annette C.
    Rotstein, Coleman
    Pappas, Peter G.
    Chapman, Stanley W.
    Kett, Daniel H.
    Kumar, Deepali
    Betts, Robert
    Wible, Michele
    Goldstein, Beth P.
    Schranz, Jennifer
    Krause, David S.
    Walsh, Thomas J.
    Van Wijngaerden, E.
    Bow, E.
    Garber, G.
    Laverdiere, M.
    Libman, M.
    Pelletier, R.
    Sanche, S.
    Cornely, O.
    Kern, W.
    Ruhnke, M.
    Carosi, G.
    Verweij, P.
    Anaissie, E.
    Bochan, M.
    Carpenter, C.
    Cicogna, C.
    Cleary, J.
    Finley, N.
    Fetchick, R.
    Friedman, B.
    Graham, D.
    Graybill, R.
    Hsiao, C.
    Jones, R.
    Kerkering, T.
    Kurtz, T.
    McClain, D.
    Nowakowski, J.
    Ostrosky-Zeichner, L.
    Perfect, J.
    Pullman, J.
    Quartin, A.
    Reinhardt, J.
    Segal, B.
    Shahryar, S.
    Shoham, S.
    Sioson, P.
    Sloan, L.
    NEW ENGLAND JOURNAL OF MEDICINE, 2007, 356 (24): : 2472 - 2482
  • [3] Cost-effectiveness analysis of anidulafungin versus fluconazole for the treatment of invasive candidiasis
    Neoh, Chin Fen
    Liew, Danny
    Slavin, Monica
    Marriott, Debbie
    Chen, Sharon C. -A.
    Morrissey, Orla
    Stewart, Kay
    Kong, David C. M.
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2011, 66 (08) : 1906 - 1915
  • [4] COST-EFFECTIVENESS ANALYSIS OF ANIDULAFUNGIN VERSUS FLUCONAZOLE FOR INVASIVE CANDIDIASIS IN MALAYSIA
    Neoh, C. F.
    Mohd, Saad M. F.
    Ismail, H.
    Mohammed, A. H.
    Hong, Y. H.
    Kong, D. C.
    VALUE IN HEALTH, 2018, 21 : S153 - S153
  • [5] A randomized, double-blind trial of anidulafungin versus fluconazole for the treatment of esophageal candidiasis
    Krause, DS
    Simjee, AE
    van Rensburg, C
    Viljoen, J
    Walsh, TJ
    Goldstein, BP
    Wible, M
    Henkel, T
    CLINICAL INFECTIOUS DISEASES, 2004, 39 (06) : 770 - 775
  • [6] Cost-effectiveness analysis of anidulafungin vs fluconazole for the treatment of invasive candidiasis (IC) in Turkey
    Neoh, Chin Fen
    Senol, Esin
    Kara, Ates
    Dinleyici, Ener Cagri
    Turner, Stuart J.
    Kong, David C. M.
    MYCOSES, 2017, 60 (11) : 714 - 722
  • [7] Efficacy of anidulafungin, caspofungin and fluconazole in the early phase of infection in a neutropenic murine invasive candidiasis model
    Krishnan-Natesan, Suganthini
    Manavathu, Elias K.
    Cutright, Jessica L.
    Chandrasekar, Pranatharthi H.
    INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2010, 36 (01) : 33 - 36
  • [8] Anidulafungin compared with fluconazole in severely ill patients with candidemia and other forms of invasive candidiasis: Support for the 2009 IDSA treatment guidelines for candidiasis
    Daniel H Kett
    Andrew F Shorr
    Annette C Reboli
    Arlene L Reisman
    Pinaki Biswas
    Haran T Schlamm
    Critical Care, 15
  • [9] Anidulafungin compared with fluconazole in severely ill patients with candidemia and other forms of invasive candidiasis: Support for the 2009 IDSA treatment guidelines for candidiasis
    Kett, Daniel H.
    Shorr, Andrew F.
    Reboli, Annette C.
    Reisman, Arlene L.
    Biswas, Pinaki
    Schlamm, Haran T.
    CRITICAL CARE, 2011, 15 (05):
  • [10] Anidulafungin for the treatment of invasive candidiasis
    Mayr, A.
    Aigner, M.
    Lass-Floerl, C.
    CLINICAL MICROBIOLOGY AND INFECTION, 2011, 17 : 1 - 12
12345